<?xml version='1.0' encoding='utf-8'?>
<document id="27511216"><sentence text="Potential drug-drug interactions in hospitalised haematological patients." /><sentence text="Background Frequently, haematological patients undergo highly complex and intensive treatment protocols, so a high risk of drug-drug interactions could be expected" /><sentence text=" Objectives To determine prevalence of clinically relevant drug-drug interactions, to identify the most frequent drug-drug interactions and associated risk factors" /><sentence text=" Methods A prospective, observational and descriptive study was carried out from November 2012 to February 2013" /><sentence text=" Twice a week, every patient's treatment sheet was collected" /><sentence text=" Each medication list was screened through two databases: Thomson MicromedexTM and Drug Interaction FactsTM" /><sentence text=" All identified potential drug-drug interactions with a moderate or higher severity rating were recorded" /><sentence text=" Summary statistics were used to describe patient and disease characteristics, most often prescribed drugs, and frequency, types and classification of drug-drug interactions" /><sentence text=" Multiple logistic regression models were used to identify risk factors associated with drug-drug interactions" /><sentence text=" Results A total of 2061 drug-drug interactions were detected in 317 treatment sheets from 58 patients" /><sentence text=" The prevalence of treatment sheets with drug-drug interactions by Micromedex and Drug Interaction Facts databases were 74" /><sentence text="1% and 56" /><sentence text="8%, respectively" /><sentence text=" Azole antifungals, immunosuppressive drugs, antiemetics, antidepressants, acid suppressants and corticosteroids were the most frequent involved drugs"><entity charOffset="1-6" id="DDI-PubMed.27511216.s14.e0" text="Azole" /><entity charOffset="97-112" id="DDI-PubMed.27511216.s14.e1" text="corticosteroids" /><pair ddi="false" e1="DDI-PubMed.27511216.s14.e0" e2="DDI-PubMed.27511216.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27511216.s14.e0" e2="DDI-PubMed.27511216.s14.e1" /></sentence><sentence text=" In multivariate analysis, the main risk factor associated with increased odds for drug-drug interactions was a higher number of non-antineoplastic drugs" /><sentence text=" Conclusions The prevalence of drug-drug interactions was common, with immunosuppressant and azole antifungal agents being the most commonly involved drugs"><entity charOffset="93-98" id="DDI-PubMed.27511216.s16.e0" text="azole" /></sentence><sentence text=" The factor having the greatest influence on drug-drug interactions was a higher number of non-antineoplastic drugs" /><sentence text="" /></document>